Cann Group (ASX:CAN), a producer of innovative cannabis medicines in Australia, has reported that their latest harvest has affirmed their progress towards reaching an annualised production volume of 12.5 tonnes at their Mildura GMP facility.

The harvest was twice the scale of previous ones, covering over 320 square meters, and was completed ahead of schedule.

The high-quality dry flower output was 17% above their target.

Cann Group has also highlighted an increase in flower quality of over 95%, and is planning further investments in automation technology to boost efficiency and margins.